Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data

Vaccine

Volumn 34, Issue 49, 2016, Pages 6057-6068

  Da Silva, Fernanda Tavares ^a   Gonik, Bernard ^b   McMillan, Mark ^c   Keech, Cheryl ^d   Dellicour, Stephanie ^e   Bhange, Shraddha ^f   Tila, Mihaela ^g   Harper, Diana M ^h   Woods, Charles ^h   Kawai, Alison Tse ⁱ   Kochhar, Sonali ^j   Munoz, Flor M ^k  

^a GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d PATH   (United States)

^e LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^f Novartis Healthcare Pvt Ltd   (India)

^g SANOFI PASTEUR   (France)

^h University of Louisville School of Medicine   (United States)

ⁱ HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

^j Healthcare Management Consultants   (India)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Adverse event; Case definition; Fetal death; Guidelines; Immunization; Stillbirth

Indexed keywords

ARTICLE; DATA ANALYSIS; FETUS DEATH; GESTATIONAL AGE; HUMAN; IMMUNIZATION; INFORMATION PROCESSING; PATIENT SAFETY; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STILLBIRTH; FEMALE;

VACCINE;

DATA COLLECTION; FEMALE; GUIDELINES AS TOPIC; HUMANS; IMMUNIZATION; PREGNANCY; RISK FACTORS; STILLBIRTH; VACCINES;

EID: 84999633699     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.03.044     Document Type: Article

References (111)

1. [1] Barfield, W., Clinical reports — standard terminology for fetal, infant, and perinatal deaths. Pediatrics, 128(July (1)), 2011.
2. [2] American College of Obstetricians and Gynecologists, Management of stillbirth. ACOG Practice Bulletin Number 102. Obstet Gynecol 113 (2009), 748–761.
3. [3] Graafmans, W.C., Richardus, J.H., MacFarlane, A., Rebagliato, M., Blondel, B., Verloove-Vanhorick, S.P., et al. Comparability of published perinatal mortality rates in Western Europe: the quantitative impact of differences in gestational age and birthweight criteria. BJOG 108:12 (2001), 1237–1245.
4. [4] Howell, E.M., Blondel, B., International infant mortality rates: bias from reporting differences. Am J Public Health 84:5 (1994), 850–852.
5. [5] World Health Organization, Neonatal and perinatal mortality country, regional and global estimates. 2006, World Health Organization, Geneva Accessed at: http://whqlibdoc.who.int/publications/2006/9241563206_eng.pdf.
6. [6] Lawn, J.E., Yakoob, M.Y., Haws, R.A., Soomro, T., Darmstadt, G.L., Bhutta, Z.A., 3.2 million stillbirths: epidemiology and overview of the evidence review. BMC Pregnancy Childbirth, 9(Suppl. 1), 2009, S2.
7. [7] Lawn, J., Gravett, M., Nunes, T., Rubens, C., Stanton, C., the GAPPS Review Group. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth, 10(Suppl. 1), 2010, S1.
8. [8] Osterman, M.J., Kochanek, K.D., MacDorman, M.F., Strobino, D.M., Guyer, B., Annual summary of vital statistics: 2012–2013. Pediatrics, 2015 pii: peds.2015-0434. Accessed at: http://pediatrics.aappublications.org/content/early/2015/04/28/peds.2015-0434.long.
9. [9] Cousens, S., Blencowe, H., Stanton, C., Chou, D., Ahmed, S., Steinhardt, L., et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet, 377, 2011, 1319.
10. [10] McClure, E.M., Nalubamba-Phiri, M., Goldenberg, R.L., Stillbirth in developing countries. Int J Gynaecol Obstet 94:August (2) (2006), 82–90.
11. [11] McClure, E.M., Wright, L.L., Goldenberg, R.L., Goudar, S.S., Parida, S.N., Jehan, I., et al. The global network: a prospective study of stillbirths in developing countries. Am J Obstet Gynecol, 197, 2007, 247.e1.
12. [12] McClure, E.M., Pasha, O., Goudar, S.S., Chomba, E., Garces, A., Tshefu, A., et al. Epidemiology of stillbirth in low-middle income countries: a Global Network Study. Acta Obstet Gynecol Scand 90:December (12) (2011), 1379–1385.
13. [13] Gissler, M., Mohangoo, A.D., Blondel, B., Chalmers, J., Macfarlane, A., Gaizauskiene, A., et al. Perinatal health monitoring in Europe: results from the EURO-PERISTAT project. Inform Health Soc Care 35:2 (2010), 64–79.
14. [14] Gregory, E.C., MacDorman, M.F., Martin, J.A., Trends in fetal and perinatal mortality in the United States, 2006–2012. NCHS Data Brief(November (169)), 2014, 1–8.
15. [15] Kramer, M.S., Liu, S., Luo, Z., Yuan, H., Platt, R.W., Joseph, K.S., Analysis of perinatal mortality and its components: time for a change?. Am J Epidemiol 156:6 (2002), 493–497.
16. [16] Say, L., Donner, A., Gülmezoglu, A.M., Taljaard, M., Piaggio, G., The prevalence of stillbirths: a systematic review. Reprod Health, 3, 2006, 1.
17. [17] Stanton, C., Lawn, J.E., Rahman, H., Wilczynska-Ketende, K., Hill, K., Stillbirth rates: delivering estimates in 190 countries. Lancet 367:May (9521) (2006), 1487–1494.
18. [18] Aminu, M., Unkels, R., Mdegela, M., Utz, B., Adaji, S., van den Broek, N., Causes of and factors associated with stillbirth in low- and middle-income countries: a systematic literature review. BJOG 121:September (Suppl. 4) (2014), 141–153.
19. [19] Balchin, I., Whittaker, J.C., Patel, R.R., Lamont, R.F., Steer, P.J., Racial variation in the association between gestational age and perinatal mortality: prospective study. BMJ, 334, 2007, 833.
20. [20] Bell, R., Glinianaia, S.V., Rankin, J., Wright, C., Pearce, M.S., Parker, L., Changing patterns of perinatal death, 1982–2000: a retrospective cohort study. Arch Dis Child Fetal Neonatal Ed, 89, 2004, F531.
21. [21] Blackwell, S., Romero, R., Chaiworapongsa, T., Kim, Y.M., Bujold, E., Espinoza, J., et al. Maternal and fetal inflammatory responses in unexplained fetal death. J Matern Fetal Neonatal Med, 14, 2003, 151.
22. [22] Gardosi, J., Madurasinghe, V., Williams, M., Malik, A., Francis, A., Maternal and fetal risk factors for stillbirth: population based study. BMJ, 346, 2013, f108.
23. [23] Getahun, D., Ananth, C.V., Kinzler, W.L., Risk factors for antepartum and intrapartum stillbirth: a population-based study. Am J Obstet Gynecol, 196, 2007, 499.
24. [24] Singh, A., Toppo, A., Re. Co. De: a better classification for determination of still births. J Obstet Gynaecol India 61:December (6) (2011), 656–658.
25. [25] Stormdal Bring, H., Hulthén Varli, I.A., Kublickas, M., Papadogiannakis, N., Pettersson, K., Causes of stillbirth at different gestational ages in singleton pregnancies. Acta Obstet Gynecol Scand 93:January (1) (2014), 86–92.
26. [26] Vergani, P., Cozzolino, S., Pozzi, E., Cuttin, M.S., Greco, M., Ornaghi, S., et al. Identifying the causes of stillbirth: a comparison of four classification systems. Am J Obstet Gynecol, 199, 2008, 319.e1.
27. [27] Gardosi, J., Kady, S.M., McGeown, P., Francis, A., Tonks, A., Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ, 331, 2005, 1113.
28. [28] Flenady, V., Frøen, J.F., Pinar, H., Torabi, R., Saastad, E., Guyon, G., et al. An evaluation of classification systems for stillbirth. BMC Pregnancy Childbirth, 9, 2009, 24.
29. [29] Cnattingius, S., Haglund, B., Kramer, M.S., Differences in late fetal death rates in association with determinants of small for gestational age fetuses: population based cohort study. BMJ, 316, 1998, 1483.
30. [30] Moyo, S.R., Hägerstrand, I., Nyström, L., Tswana, S.A., Blomberg, J., Bergström, S., et al. Stillbirths and intrauterine infection, histologic chorioamnionitis and microbiological findings. Int J Gynaecol Obstet 54 (1996), 115–123.
31. [31] Osman, N.B., Folgosa, E., Gonzales, C., Bergström, S., Genital infections in the aetiology of late fetal death: an incident case referent study. J Trop Pediatr 41 (1995), 258–266.
32. [32] Williams, E.J., Embleton, N.D., Clark, J.E., Bythell, M., Ward Platt, M.P., et al. Viral infections: contributions to late fetal death, stillbirth, and infant death. J Pediatr, 163, 2013, 424.
33. [33] Stephansson, O., Dickman, P.W., Johansson, A., Cnattingius, S., Maternal hemoglobin concentration during pregnancy and risk of stillbirth. JAMA, 284, 2000, 2611.
34. [34] Bukowski, R., Hansen, N.I., Willinger, M., Reddy, U.M., Parker, C.B., Pinar, H., et al. Fetal growth and risk of stillbirth: a population-based case–control study. PLoS Med, 11, 2014, e1001633.
35. [35] Frøen, J.F., Gardosi, J.O., Thurmann, A., Francis, A., Stray-Pedersen, B., Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand, 83, 2004, 801.
36. [36] Zhang, J., Klebanoff, M.A., Small-for-gestational-age infants and risk of fetal death in subsequent pregnancies. N Engl J Med, 350, 2004, 754.
37. [37] Goldenberg, R.L., McClure, E.M., Saleem, S., Reddy, U.M., Infection-related stillbirths. Lancet, 375, 2010, 1482.
38. [38] Stillbirth Collaborative Research Network Writing Group, Causes of death among stillbirths. JAMA, 306, 2011, 2459.
39. [39] Silver, R.M., Varner, M.W., Reddy, U., Goldenberg, R., Pinar, H., Conway, D., et al. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol, 196, 2007, 433.
40. [40] Carey, J.C., Rayburn, W.F., Nuchal cord encirclements and risk of stillbirth. Int J Gynaecol Obstet, 69, 2000, 173.
41. [41] Woods, R., Long-term trends in fetal mortality: implications for developing countries. Bull World Health Organ 86:6 (2008), 460–466.
42. [42] Reddy, U.M., Goldenberg, R., Silver, R., Smith, G.C., Pauli, R.M., Wapner, R.J., et al. Stillbirth classification – developing an international consensus for research: executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol, 114, 2009, 901 [Erratum in: Obstet Gynecol. 2010 Jan; 115(1):191].
43. [43] Reddy, U.M., Laughon, S.K., Sun, L., Troendle, J., Willinger, M., Zhang, J., Pregnancy risk factors for antepartum stillbirth in the United States. Obstet Gynecol, 116, 2010, 1119.
44. [44] Di Mario, S., Say, L., Lincetto, O., Risk factors for stillbirth in developing countries: a systematic review of the literature. Sex Transm Dis, 34, 2007, S11.
45. [45] Flenady, V., Koopmans, L., Middleton, P., Frøen, J.F., Smith, G.C., Gibbons, K., et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet, 377, 2011, 1331.
46. [46] Frøen, J.F., Arnestad, M., Frey, K., Vege, A., Saugstad, O.D., Stray-Pedersen, B., Risk factors for sudden intrauterine unexplained death: epidemiologic characteristics of singleton cases in Oslo, Norway, 1986–1995. Am J Obstet Gynecol, 184, 2001, 694.
47. [47] Liu, L.C., Wang, Y.C., Yu, M.H., Su, H.Y., Major risk factors for stillbirth in different trimesters of pregnancy – a systematic review. Taiwan J Obstet Gynecol 53:June (2) (2014), 141–145.
48. [48] Varner, M.W., Silver, R.M., Rowland Hogue, C.J., Willinger, M., Parker, C.B., Thorsten, V.R., et al. Association between stillbirth and illicit drug use and smoking during pregnancy. Obstet Gynecol, 123, 2014, 113.
49. [49] Stephansson, O., Dickman, P.W., Johansson, A., Cnattingius, S., Maternal weight, pregnancy weight gain, and the risk of antepartum stillbirth. Am J Obstet Gynecol, 184, 2001, 463.
50. [50] Stillbirth Collaborative Research Network Writing Group, Association between stillbirth and risk factors known at pregnancy confirmation. JAMA, 306, 2011, 2469.
51. [51] Willinger, M., Ko, C.W., Reddy, U.M., Racial disparities in stillbirth risk across gestation in the United States. Am J Obstet Gynecol, 201, 2009, 469.e1.
52. [52] Lawn, J.E., Blencowe, H., Pattinson, R., Cousens, S., Kumar, R., Ibiebele, I., et al. Stillbirths: Where? When? Why? How to make the data count?. Lancet 377 (2011), 1448–1463.
53. [53] Harbour, R., Miller, J., A new system for grading recommendations in evidence based guidelines. BMJ 323 (2001), 334–336.
54. [54] Linde, A., Pettersson, K., Rådestad, I., Women's experiences of fetal movements before the confirmation of fetal death-contractions misinterpreted as fetal movement. Birth, 42, 2015, 2.
55. [55] Langley, F.A., The perinatal postmortem examination. J Clin Pathol 24 (1971), 159–169.
56. [56] McCully, J.G., Gas in the fetal joints: a sign of intrauterine death. Obstet Gynecol 36 (1970), 433–436.
57. [57] Shaff, M.I., An evaluation of radiological signs of fetal death. S Afr Med J, 49, 1975, 736.
58. [58] Soo, Y.S., Three common radiological signs of intrauterine fetal death. J Asian Fed Obstet Gynecol, 2, 1971, 20.
59. [59] Weinstein, B.J., Platt, L.D., The ultrasonic appearance of intravascular gas in fetal death. J Ultrasound Med 2 (1983), 451–454.
60. [60] Zeit, R.M., Sonographic demonstration of fetal death in the absence of radiographic abnormality. Obstet Gynecol 48:1 Suppl (1976), 49S–52S.
61. [61] Bratton, K.N., Wardle, M.T., Orenstein, W.A., Omer, S.B., Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis. Clin Infect Dis 60:5 (2015), e11–e19.
62. [62] Cantu, J., Biggio, J., Jauk, V., Wetta, L., Andrews, W., Tita, A., Selective uptake of influenza vaccine and pregnancy outcomes. J Matern Fetal Neonatal Med 26:12 (2013), 1207–1211.
63. [63] Chambers, C.D., Johnson, D.L., Xu, R., Risks and safety of pandemic H1N1 vaccine in pregnancy: birth defects, spontaneous abortion, preterm birth, and small for gestational age infants. Pharmacoepidem Drug Saf 22:44 (2013), 14–15.
64. [64] Deinard, A.S., Ogburn, P., A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. Am J Obstet Gynecol 140:3 (1981), 240–245.
65. [65] Demicheli, V., Jefferson, T., Al-Ansary, L.A., Ferroni, E., Rivetti, A., Di Pietrantonj, C., Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev(3), 2014, 10.1002/14651858.CD001269.pub5 AN CD001269.
66. [66] Fell, D.B., Sprague, A.E., Liu, N., Yasseen, A.S. 3rd, Wen, S.W., Smith, G., et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health 102:6 (2012), e33–e40.
67. [67] Fell, D.B., Platt, R.W., Lanes, A., Wilson, K., Kaufman, J.S., Basso, O., Buckeridge, D., Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG, 2014.
68. [68] Håberg, S.E., Trogstad, L., Gunnes, N., Wilcox, A.J., Gjessing, H.K., Samuelsen, S.O., et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 368 (2013), 333–340.
69. [69] Heikkinen, T., Young, J., van Beek, E., Franke, H., Verstraeten, T., Weil, J.G., et al. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 207:3 (2012), 177.e1–177.e8.
70. [70] McMillan, M., Porritt, K., Kralik, D., Costi, L., Marshall, H., Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine 33:April (18) (2015), 2108–2117.
71. [71] Pasternak, B., Svanström, H., Mølgaard-Nielsen, D., Krause, T.G., Emborg, H.D., Melbye, M., et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: Cohort study in Denmark. BMJ, 344(7857), 2012, e2794.
72. [72] Advisory Committee on Immunization Practices (ACIP), Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women. MMWR 62:7 (2013), 131–135.
73. [73] Fabiani, M., Bella, A., Rota, M.C., Clagnan, E., Gallo, T., D'Amato, M., et al. A/H1N1 pandemic influenza vaccination: a retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy. Vaccine 33:19 (2015), 2240–2247.
74. [74] Huang, W.T., Tang, F.W., Yang, S.E., Chih, Y.C., Chuang, J.H., Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan. Vaccine 32:48 (2014), 6463–6468.
75. [75] Tavares, F., Nazareth, I., Monegal, J., Kolte, I., Verstraeten, T., Bauchau, V., Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine 29:August (37) (2011), 6358–6365.
76. [76] Donegan, K., King, B., Bryan, P., Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ, 349, 2014, g4219.
77. [77] Morgan, J., Baggari, S., McIntire, D., Sheffield, J., Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination. Obstet Gynecol 125:6 (2015), 1433–1438.
78. [78] Munoz, F.M., Bond, N.H., Maccato, M., Pinell, P., Hammill, H.A., Swamy, G.K., et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 311:17 (2014), 1760–1769.
79. [79] Shakib, J., Korgenski, K., Sheng, X., Varner, M., Pavia, A., Byington, C., Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr 163:5 (2013), 1422–1426 e1–4.
80. [80] Talbot, E.A., Brown, K.H., Kirkland, K.B., Baughman, A.L., Halperin, S.A., Broder, K.R., The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine 28:50 (2010), 8001–8007.
81. [81] Zheteyeva, Y.A., Moro, P.L., Tepper, N.K., Rasmussen, S.A., Barash, F.E., Revzina, N.V., et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 207:1 (2012), 59.e1–59.e7.
82. [82] Keller-Stanislawski, B., Englund, J.A., Kang, G., Mangtani, P., Neuzil, K., Nohynek, H., et al. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 32:52 (2014), 7057–7064.
83. [83] Rasmussen, S.A., Watson, A.K., Kennedy, E.D., Broder, K.R., Jamieson, D.J., Vaccines and pregnancy: past, present, and future. Semin Fetal Neonatal Med 19:3 (2014), 161–169.
84. [84] Sato, H.K., Sanajotta, A.T., Moraes, J.C., Andrade, J.Q., Duarte, G., Cervi, M.C., et al. Rubella vaccination of unknowingly pregnant women: the Sao Paulo experience, 2001. J Infect Dis 204:Suppl. 2 (2011), S737–S744.
85. [85] Bar-Oz, B., Levichek, Z., Moretti, M.E., Mah, C., Andreou, S., Koren, G., Pregnancy outcome following rubella vaccination: a prospective controlled study. Am J Med Genet Part A 130A:1 (2004), 52–54.
86. [86] Badilla, X., Morice, A., Avila-Aguero, M.L., Saenz, E., Cerda, I., Reef, S., et al. Fetal risk associated with rubella vaccination during pregnancy. Pediatr Infect Dis J 26:9 (2007), 830–835.
87. [87] Badell, M.L., Meaney-Delman, D., Tuuli, M.G., Rasmussen, S.A., Petersen, B.W., Sheffield, J.S., et al. Risks associated with smallpox vaccination in pregnancy: a systematic review and meta-analysis. Obstet Gynecol 125:6 (2015), 1439–1451.
88. [88] Harjulehto-Mervaala, T., Aro, T., Hiilesmaa, V.K., Hovi, T., Saxen, H., Saxen, L., Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome. Clin Infect Dis 18:3 (1994), 414–420.
89. [89] Kohl, K.S., Gidudu, J., Bonhoeffer, J., Braun, M.M., Buettcher, M., ChenRT, et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine 25 (2007), 5671–5674.
90. [90] World Health Organization, International statistical classification of diseases and related health problems ICD-10, 10th revision, vol. 2, 2004, World Health Organization, Geneva Accessed at: http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2444.
91. [91] Gourbin, G., Masuy-Stroobant, G., Registration of vital data: are live births and stillbirths comparable all over Europe?. Bull World Health Organ 73:4 (1995), 449–460.
92. [92] Kowaleski, J., State definitions and reporting requirements for live births, fetal deaths, and induced terminations of pregnancy (1997 revision). 1997, National Center for Health Statistics, Hyattsville, MD Accessed at: http://www.cdc.gov/nchs/data/misc/itop97.pdf.
93. [93] Smith GC1, Fretts, R.C., Stillbirth. Lancet 370:November (9600) (2007), 1715–1725.
94. [94] Dudley, D.J., Goldenberg, R., Conway, D., Silver, R.M., Saade, G.R., Varner, M.W., et al. A new system for determining the causes of stillbirth. Stillbirth Research Collaborative Network. Obstet Gynecol 116:August (2 Pt 1) (2010), 254–260.
95. [95] Korteweg, F.J., Gordijn, S.J., Timmer, A., Erwich, J.J., Bergman, K.A., Bouman, K., et al. The Tulip classification of perinatal mortality: introduction and multidisciplinary inter-rater agreement. BJOG, 113, 2006, 393.
96. [96] Varli, I.H., Petersson, K., Bottinga, R., Bremme, K., Hofsjö, A., Holm, M., et al. The Stockholm classification of stillbirth. Acta Obstet Gynecol Scand, 87, 2008, 1202.
97. [97] Duke, C.W., Correa, A., Romitti, P.A., Martin, J., Kirby, R.S., Challenges and priorities for surveillance of stillbirths: a report on two workshops. Public Health Rep 124:September–October (5) (2009), 652–659.
98. [98] Gardosi, J., Kady, S.M., McGeown, P., Francis, A., Tonks, A., Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ, 331, 2005, 1113.
99. [99] Chan, A., King, J.F., Flenady, V., Haslam, R.H., Tudehope, D.I., Classification of perinatal deaths: development of the Australian and New Zealand classifications. J Paediatr Child Health, 40, 2004, 340.
100. [100] Conway, D., An algorithm for the estimation of gestational age at the time of fetal death. Paediatr Perinat Epidemiol 27:March (2) (2013), 145–157.
101. [101] Hirst, J.E., Ha, L.T., Jeffery, H.E., The use of fetal foot length to determine stillborn gestational age in Vietnam. Int J Gynaecol Obstet 116:January (1) (2012), 22–25.
102. [102] European Medicines Agency (Committee for Medicinal Products for Human Use), Guideline on the exposure to medicinal products during pregnancy: need for post-authorization data. 2005, EMEA, London, UK Accessed at: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/11/WC500011303.pdf.
103. [103] Lahra, M.M., Gordon, A., Jeffery, H.E., Chorioamnionitis and fetal response in stillbirth. Am J Obstet Gynecol 196:3 (2007), 229.e1–229.e4.
104. [104] Taylor, L., Hospital procedures for review and reporting of perinatal deaths: Epidemiology and Surveillance Branch NSW Health. 2006 Accessed at: http://www.health.nsw.gov.au/policies/GL/2005/pdf/GL2005_013.pdf.
105. [105] Births and Deaths Registration (Northern Ireland) Order 1976. Legislation.gov.uk. Accessed at: http://www.legislation.gov.uk/nisi/1976/1041.
106. [106] Birth Summary Tables, England and Wales. Office for National Statistics, Birth statistics 2008. Series FM1 No. 37. 2010 Accessed at: http://www.ons.gov.uk/ons/rel/vsob1/birth-summary-tables–england-and-wales/2008–final-/index.html.
107. [107] International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidelines for Clinical Safety assessment (E2a-e). Accessed at: http://www.ich.org/.
108. [108] Council for International Organizations of Medical Sciences (CIOMS). Reporting form for International Reporting of Adverse Drug Reactions. Accessed at: http://www.cioms.ch/.
109. [109] The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285:15 (2001), 1987–1991 Accessed at: http://www.consort-statement.org/.
110. [110] Moher, D., Cook, D.J., Eastwood, S., Olkin, I., Rennie, D., Stroup, D.F., Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354:9193 (1999), 1896–1900 Accessed at: http://www.consort-statement.org/.
111. [111] Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:15 (2000), 2008–2012 Accessed at: http://www.consort-statement.org/.